Impaired anti-fibrotic effect of bone marrow-derived mesenchymal stem cell in a mouse model of pulmonary paracoccidioidomycosis.

Bone marrow-derived mesenchymal stem cells (BMMSCs) have been consider as a promising therapy in fibrotic diseases. Experimental models suggest that BMMSCs may be used as an alternative therapy to treat chemical- or physical-induced pulmonary fibrosis. We investigated the anti-fibrotic potential of...

Full description

Bibliographic Details
Main Authors: Julián Camilo Arango, Juan David Puerta-Arias, Paula Andrea Pino-Tamayo, Lina María Salazar-Peláez, Mauricio Rojas, Ángel González
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-10-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC5659794?pdf=render
id doaj-d515baa289e84bc7b3cb27de1d88e1ac
record_format Article
spelling doaj-d515baa289e84bc7b3cb27de1d88e1ac2020-11-25T01:45:07ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352017-10-011110e000600610.1371/journal.pntd.0006006Impaired anti-fibrotic effect of bone marrow-derived mesenchymal stem cell in a mouse model of pulmonary paracoccidioidomycosis.Julián Camilo ArangoJuan David Puerta-AriasPaula Andrea Pino-TamayoLina María Salazar-PeláezMauricio RojasÁngel GonzálezBone marrow-derived mesenchymal stem cells (BMMSCs) have been consider as a promising therapy in fibrotic diseases. Experimental models suggest that BMMSCs may be used as an alternative therapy to treat chemical- or physical-induced pulmonary fibrosis. We investigated the anti-fibrotic potential of BMMSCs in an experimental model of lung fibrosis by infection with Paracoccidioides brasiliensis. BMMSCs were isolated and purified from BALB/c mice using standardized methods. BALB/c male mice were inoculated by intranasal infection of 1.5x106 P. brasiliensis yeasts. Then, 1x106 BMMSCs were administered intra venous at 8th week post-infection (p.i.). An additional group of mice was treated with itraconazole (ITC) two weeks before BMMSCs administration. Animals were sacrificed at 12th week p.i. Histopathological examination, fibrocytes counts, soluble collagen and fibrosis-related genes expression in lungs were evaluated. Additionally, human fibroblasts were treated with homogenized lung supernatants (HLS) to determine induction of collagen expression. Histological analysis showed an increase of granulomatous inflammatory areas in BMMSCs-treated mice. A significant increase of fibrocytes count, soluble collagen and collagen-3α1, TGF-β3, MMP-8 and MMP-15 genes expression were also observed in those mice. Interestingly, when combined therapy BMMSCs/ITC was used there is a decrease of TIMP-1 and MMP-13 gene expression in infected mice. Finally, human fibroblasts stimulated with HLS from infected and BMMSCs-transplanted mice showed a higher expression of collagen I. In conclusion, our findings indicate that late infusion of BMMSCs into mice infected with P. brasiliensis does not have any anti-fibrotic effect; possibly because their interaction with the fungus promotes collagen expression and tissue remodeling.http://europepmc.org/articles/PMC5659794?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Julián Camilo Arango
Juan David Puerta-Arias
Paula Andrea Pino-Tamayo
Lina María Salazar-Peláez
Mauricio Rojas
Ángel González
spellingShingle Julián Camilo Arango
Juan David Puerta-Arias
Paula Andrea Pino-Tamayo
Lina María Salazar-Peláez
Mauricio Rojas
Ángel González
Impaired anti-fibrotic effect of bone marrow-derived mesenchymal stem cell in a mouse model of pulmonary paracoccidioidomycosis.
PLoS Neglected Tropical Diseases
author_facet Julián Camilo Arango
Juan David Puerta-Arias
Paula Andrea Pino-Tamayo
Lina María Salazar-Peláez
Mauricio Rojas
Ángel González
author_sort Julián Camilo Arango
title Impaired anti-fibrotic effect of bone marrow-derived mesenchymal stem cell in a mouse model of pulmonary paracoccidioidomycosis.
title_short Impaired anti-fibrotic effect of bone marrow-derived mesenchymal stem cell in a mouse model of pulmonary paracoccidioidomycosis.
title_full Impaired anti-fibrotic effect of bone marrow-derived mesenchymal stem cell in a mouse model of pulmonary paracoccidioidomycosis.
title_fullStr Impaired anti-fibrotic effect of bone marrow-derived mesenchymal stem cell in a mouse model of pulmonary paracoccidioidomycosis.
title_full_unstemmed Impaired anti-fibrotic effect of bone marrow-derived mesenchymal stem cell in a mouse model of pulmonary paracoccidioidomycosis.
title_sort impaired anti-fibrotic effect of bone marrow-derived mesenchymal stem cell in a mouse model of pulmonary paracoccidioidomycosis.
publisher Public Library of Science (PLoS)
series PLoS Neglected Tropical Diseases
issn 1935-2727
1935-2735
publishDate 2017-10-01
description Bone marrow-derived mesenchymal stem cells (BMMSCs) have been consider as a promising therapy in fibrotic diseases. Experimental models suggest that BMMSCs may be used as an alternative therapy to treat chemical- or physical-induced pulmonary fibrosis. We investigated the anti-fibrotic potential of BMMSCs in an experimental model of lung fibrosis by infection with Paracoccidioides brasiliensis. BMMSCs were isolated and purified from BALB/c mice using standardized methods. BALB/c male mice were inoculated by intranasal infection of 1.5x106 P. brasiliensis yeasts. Then, 1x106 BMMSCs were administered intra venous at 8th week post-infection (p.i.). An additional group of mice was treated with itraconazole (ITC) two weeks before BMMSCs administration. Animals were sacrificed at 12th week p.i. Histopathological examination, fibrocytes counts, soluble collagen and fibrosis-related genes expression in lungs were evaluated. Additionally, human fibroblasts were treated with homogenized lung supernatants (HLS) to determine induction of collagen expression. Histological analysis showed an increase of granulomatous inflammatory areas in BMMSCs-treated mice. A significant increase of fibrocytes count, soluble collagen and collagen-3α1, TGF-β3, MMP-8 and MMP-15 genes expression were also observed in those mice. Interestingly, when combined therapy BMMSCs/ITC was used there is a decrease of TIMP-1 and MMP-13 gene expression in infected mice. Finally, human fibroblasts stimulated with HLS from infected and BMMSCs-transplanted mice showed a higher expression of collagen I. In conclusion, our findings indicate that late infusion of BMMSCs into mice infected with P. brasiliensis does not have any anti-fibrotic effect; possibly because their interaction with the fungus promotes collagen expression and tissue remodeling.
url http://europepmc.org/articles/PMC5659794?pdf=render
work_keys_str_mv AT juliancamiloarango impairedantifibroticeffectofbonemarrowderivedmesenchymalstemcellinamousemodelofpulmonaryparacoccidioidomycosis
AT juandavidpuertaarias impairedantifibroticeffectofbonemarrowderivedmesenchymalstemcellinamousemodelofpulmonaryparacoccidioidomycosis
AT paulaandreapinotamayo impairedantifibroticeffectofbonemarrowderivedmesenchymalstemcellinamousemodelofpulmonaryparacoccidioidomycosis
AT linamariasalazarpelaez impairedantifibroticeffectofbonemarrowderivedmesenchymalstemcellinamousemodelofpulmonaryparacoccidioidomycosis
AT mauriciorojas impairedantifibroticeffectofbonemarrowderivedmesenchymalstemcellinamousemodelofpulmonaryparacoccidioidomycosis
AT angelgonzalez impairedantifibroticeffectofbonemarrowderivedmesenchymalstemcellinamousemodelofpulmonaryparacoccidioidomycosis
_version_ 1725025134726610944